Macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors with activity in vivo
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (5) , 1366-1370
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Structure-Based Design, Synthesis, and Memapsin 2 (BACE) Inhibitory Activity of Carbocyclic and Heterocyclic PeptidomimeticsJournal of Medicinal Chemistry, 2005
- Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generationThe EMBO Journal, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generationNature Neuroscience, 2001
- Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activityNature, 1999
- Purification and cloning of amyloid precursor protein β-secretase from human brainNature, 1999
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984
- über eigenartige Krankheitsfälle des späteren AltersZeitschrift für die gesamte Neurologie und Psychiatrie, 1911